Clinical Trials Directory

Trials / Completed

CompletedNCT05651867

EPIONE Guided Lung Evaluation

Prospective Clinical Investigation on the Evaluation of Performance and Safety of the EPIONE Assisted CT-guided Percutaneous Procedures in the Lungs

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Quantum Surgical · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Interventional clinical study to obtain performance and safety data of the EPIONE® device when used for percutaneous procedures in the lung.

Detailed description

The objectives are: * to evaluate the technical success of the device * to evaluate performance parameters (accuracy measures, adjustements, post-intervention ablation success, local tumor recurrence) * to evaluate the safety of the device 25 subjectsare planned and will undergo an intervention, during which the clinician will use the EPIONE device

Conditions

Interventions

TypeNameDescription
DEVICEEPIONE deviceThe EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous procedures.

Timeline

Start date
2022-11-28
Primary completion
2023-08-25
Completion
2024-09-10
First posted
2022-12-15
Last updated
2025-07-15
Results posted
2025-07-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05651867. Inclusion in this directory is not an endorsement.

EPIONE Guided Lung Evaluation (NCT05651867) · Clinical Trials Directory